Results for Cognitive Decline/Dysfunction

A 5-min bout of walking at a self-selected intensity is associated with improved cognitive function.

Article Published Date : Jan 04, 2018
Study Type : Human Study
Additional Links
Diseases : Cognitive Decline/Dysfunction : CK(5292) : AC(1050)
Therapeutic Actions : Exercise : CK(6919) : AC(1026)
Additional Keywords : Cognitive Decline/Dysfunction

Aluminum can induce neuroinflammation and could lead to learning and memory deficits.

Article Published Date : Apr 30, 2016
Study Type : Animal Study
Additional Links
Diseases : Aluminum Toxicity : CK(735) : AC(318), Brain Inflammation : CK(1784) : AC(928), Cognitive Decline/Dysfunction : CK(5292) : AC(1050)
Additional Keywords : aluminum, aluminum toxicity, Brain Inflammation, Cognitive Decline/Dysfunction
Problem Substances : Aluminum : CK(1075) : AC(356)
Adverse Pharmacological Actions : Inflammatory : CK(554) : AC(176)

Bacopa monnieri supplementation could theoretically enhance and strengthen synaptic changes acquired through cognitive training.

Article Published Date : Sep 30, 2016
Study Type : Commentary
Additional Links
Substances : Bacopa : CK(337) : AC(153)
Diseases : Cognitive Decline/Dysfunction : CK(5292) : AC(1050)
Therapeutic Actions : Cognitive Behavioural Approaches : CK(61) : AC(7), Integrative Medicine : CK(501) : AC(69)
Additional Keywords : Bacopa, Cognitive Behavioural Approaches, Cognitive Decline/Dysfunction, Integrative Medicine

Being physically active during early adulthood and midlife contributes to prevention of poor subjective cognitive function in late-life.

Article Published Date : Nov 16, 2017
Study Type : Human Study
Additional Links
Diseases : Aging: Brain : CK(1118) : AC(268), Cognitive Decline/Dysfunction : CK(5292) : AC(1050)
Therapeutic Actions : Exercise : CK(6919) : AC(1026)
Additional Keywords : Aging: Brain, Cognitive Decline/Dysfunction, exercise

Brahmi could be a new frontier of restoration and prevention of cognitive deficit in schizophrenia.

Article Published Date : Nov 30, 2016
Study Type : Animal Study
Additional Links
Substances : Bacopa : CK(337) : AC(153)
Diseases : Cognitive Decline/Dysfunction : CK(5292) : AC(1050), Schizophrenia : CK(1107) : AC(199)
Pharmacological Actions : Neuroprotective Agents : CK(20061) : AC(7949)
Additional Keywords : Bacopa, Cognitive Decline/Dysfunction, Neuroprotective Agents, Plant Extracts : CK(18762) : AC(6782), Schizophrenia

Epidemiological evidence supports associations between low serum 25(OH)D concentrations and poorer cognitive performance in community-dwelling older populations

Article Published Date : Dec 12, 2017
Study Type : Review
Additional Links
Substances : Vitamin D : CK(11762) : AC(1712)
Diseases : Cognitive Decline/Dysfunction : CK(5292) : AC(1050), Vitamin D Deficiency : CK(7036) : AC(837)
Additional Keywords : Cognitive Decline/Dysfunction, Risk Factors : CK(14901) : AC(2085), VITAMIN D, Vitamin D Deficiency

Ginkgo biloba extract twice-daily for at least 6 months may improve dual-task-related gait performance in patients with mild cognitive impairment.

Article Published Date : Feb 07, 2017
Study Type : Human Study
Additional Links
Substances : Ginkgo biloba : CK(2047) : AC(658)
Diseases : Cognitive Decline/Dysfunction : CK(5292) : AC(1050)
Pharmacological Actions : Neuroprotective Agents : CK(20061) : AC(7949)
Additional Keywords : Cognitive Decline/Dysfunction, ginkgo biloba, Neuroprotective Agents

Harmine could ameliorate impaired memory by enhancement of cholinergic neurotransmission.

Article Published Date : Dec 04, 2015
Study Type : Animal Study
Additional Links
Substances : Syrian rue : CK(84) : AC(51)
Diseases : Alzheimer's Disease : CK(5355) : AC(2210), Cognitive Decline/Dysfunction : CK(5292) : AC(1050)
Pharmacological Actions : Acetylcholinesterase Inhibitor : CK(259) : AC(128), Neuroprotective Agents : CK(20061) : AC(7949)
Additional Keywords : Acetylcholinesterase Inhibitor, Alzheimer's disease, Cognitive Decline/Dysfunction, Neuroprotective Agents, Syrian rue

Intermittent fasting may prevent some of the metabolic pathologies associated with menopause and protect against age-related memory decline.

Article Published Date : Jan 31, 2018
Study Type : Animal Study
Additional Links
Diseases : Aging: Brain : CK(1118) : AC(268), Cognitive Decline/Dysfunction : CK(5292) : AC(1050), Postmenopausal Disorders: Memory Impairment : CK(31) : AC(14)
Therapeutic Actions : Fasting/Caloric Restriction : CK(820) : AC(176)
Pharmacological Actions : Neuroprotective Agents : CK(20061) : AC(7949)
Additional Keywords : Aging: Brain, Cognitive Decline/Dysfunction, Fasting/Caloric Restriction, Neuroprotective Agents

Lavender oil and especially linalool could be a potential agent for improving cognitive impairment in Alzheimer's disease.

Article Published Date : Dec 31, 2016
Study Type : Animal Study
Additional Links
Substances : Lavender : CK(656) : AC(100), Lavender: Essential Oil : CK(472) : AC(75)
Diseases : Alzheimer's Disease : CK(5355) : AC(2210), Cognitive Decline/Dysfunction : CK(5292) : AC(1050)
Pharmacological Actions : Antioxidants : CK(34551) : AC(14499), Heme oxygenase-1 up-regulation : CK(1336) : AC(776), Neuroprotective Agents : CK(20061) : AC(7949), Nrf2 activation : CK(3156) : AC(1794)
Additional Keywords : Alzheimer's disease, Antioxidants : CK(303) : AC(126), Cognitive Decline/Dysfunction, lavender, Lavender: Essential Oil
Problem Substances : Aluminum : CK(1075) : AC(356)

Leisure activity involvement may help delay cognitive impairment.

Article Published Date : Sep 30, 2017
Study Type : Human Study
Additional Links
Diseases : Aging: Brain : CK(1118) : AC(268), Cognitive Decline/Dysfunction : CK(5292) : AC(1050)
Therapeutic Actions : Exercise : CK(6919) : AC(1026)
Additional Keywords : Aging: Brain, Cognitive Decline/Dysfunction, exercise, Physical Activity : CK(518) : AC(58), Risk Reduction : CK(17935) : AC(2006)

Serum homocysteine may play a role in cognitive dysfunction in MS patients.

Article Published Date : Feb 20, 2018
Study Type : Human Study
Additional Links
Diseases : Cognitive Decline/Dysfunction : CK(5292) : AC(1050), Homocysteine: Elevated : CK(780) : AC(113), Multiple Sclerosis : CK(2432) : AC(557)
Additional Keywords : Cognitive Decline/Dysfunction, Homocysteine: Elevated, Multiple Sclerosis : CK(38) : AC(8), Risk Factors : CK(14901) : AC(2085)

Subjects with exercise habits show larger subcortical gray matter volumes than subjects without exercise habits in elderly subjects in Japan.

Article Published Date : May 31, 2017
Study Type : Human Study
Additional Links
Diseases : Cognitive Decline/Dysfunction : CK(5292) : AC(1050), Dementia : CK(2211) : AC(386)
Therapeutic Actions : Exercise : CK(6919) : AC(1026)
Pharmacological Actions : Neuroprotective Agents : CK(20061) : AC(7949)
Additional Keywords : Cognitive Decline/Dysfunction, dementia, exercise, Neuroprotective Agents

The current review discusses the efficacy of exercise and yoga to ameliorate depression and thereby reduce the risk of cognitive decline.

Article Published Date : Dec 31, 2015
Study Type : Review
Additional Links
Diseases : Cognitive Decline/Dysfunction : CK(5292) : AC(1050), Dementia : CK(2211) : AC(386), Depression
Therapeutic Actions : Exercise : CK(6919) : AC(1026), Yoga : CK(3795) : AC(428)
Additional Keywords : Cognitive Decline/Dysfunction, dementia, Depression : CK(108) : AC(19), exercise, yoga

The results of the present study suggested that vanillin may be beneficial for cognitive impairment.

Article Published Date : Feb 28, 2018
Study Type : Animal Study
Additional Links
Substances : Vanillin : CK(90) : AC(54)
Diseases : Cognitive Decline/Dysfunction : CK(5292) : AC(1050)
Pharmacological Actions : Neuroprotective Agents : CK(20061) : AC(7949)
Additional Keywords : Cognitive Decline/Dysfunction, Neuroprotective Agents, Vanillin

These findings add new experimental data for potential therapeutic effects of resveratrol in the brain in a model of subacute systemic inflammation.

Article Published Date : Dec 31, 2016
Study Type : Animal Study, In Vitro Study
Additional Links
Substances : Resveratrol : CK(3228) : AC(1513)
Diseases : Brain Inflammation : CK(1784) : AC(928), Cognitive Decline/Dysfunction : CK(5292) : AC(1050)
Pharmacological Actions : Anti-Inflammatory Agents : CK(39737) : AC(15858), Neuroprotective Agents : CK(20061) : AC(7949)
Additional Keywords : Anti-Inflammatory Agents, Brain Inflammation, Cognitive Decline/Dysfunction, Dose Response : CK(1770) : AC(700), Neuroprotective Agents, RESVERATROL

Vitamin C could remit isoflurane-induced apoptosis and relieve the decline in learning and memory ability of rats.

Article Published Date : Sep 30, 2016
Study Type : Animal Study
Additional Links
Substances : Vitamin C : CK(6066) : AC(1408)
Diseases : Cognitive Decline/Dysfunction : CK(5292) : AC(1050), Surgery: Anesthesiology : CK(141) : AC(28)
Pharmacological Actions : Anti-Apoptotic : CK(5568) : AC(3160)
Additional Keywords : Anti-Apoptotic, Cognitive Decline/Dysfunction, Risk Reduction : CK(17935) : AC(2006), Surgery: Anesthesiology, Vitamin C : CK(48) : AC(13)

Connect with GreenMedInfo